Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets


Chronic inflammation drives the development of atherosclerosis, and adaptive immunity is deeply involved in this process. Initial studies attributed a pathogenic role to T cells in atherosclerosis, mainly owing to the proatherogenic role of the T-helper (TH)-1 cell subset, whereas the influence of TH2 and TH17 subsets is still debated. Today we know that T regulatory cells play a critical role in the protection against atherosclerotic lesion development and inflammation. In contrast to T cells, B cells were initially considered to be protective in atherosclerosis, assumingly through the production of protective antibodies against oxidized LDL. This concept has now been refined and proatherogenic roles of certain mature B cell subsets have been identified. We review the current knowledge about the role of various lymphocyte subsets in the development and progression of atherosclerosis and highlight future targets for immunomodulatory therapy.

DOI: 10.1038/nrcardio.2011.62
Citations per Year

568 Citations

Semantic Scholar estimates that this publication has 568 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Lahoute2011AdaptiveII, title={Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets}, author={Charlotte Lahoute and Olivier Herbin and Ziad Mallat and Alain Tedgui}, journal={Nature Reviews Cardiology}, year={2011}, volume={8}, pages={348-358} }